{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:37:40Z","timestamp":1788244660114,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","mayoclinicproceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.mayocp.2015.10.027","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T14:28:24Z","timestamp":1452004104000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Heavy Testosterone Use Among Bodybuilders"],"prefix":"10.1016","volume":"91","author":[{"given":"Mary E.","family":"Westerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron M.","family":"Charchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Ziegelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd B.","family":"Nippoldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon","family":"Trost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mayocp.2015.10.027_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.pcl.2007.04.003","article-title":"The history of the development of anabolic-androgenic steroids","volume":"54","author":"Dotson","year":"2007","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"10.1016\/j.mayocp.2015.10.027_bib2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/bjp.2008.165","article-title":"Pharmacology of anabolic steroids","volume":"154","author":"Kicman","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.10.027_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00042752-199510000-00003","article-title":"Fat-free mass index in users and nonusers of anabolic-androgenic steroids","volume":"5","author":"Kouri","year":"1995","journal-title":"Clin J Sport Med"},{"issue":"9627","key":"10.1016\/j.mayocp.2015.10.027_bib4","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/S0140-6736(08)60801-6","article-title":"Use of doping agents, particularly anabolic steroids, in sports and society","volume":"371","author":"Sjoqvist","year":"2008","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.mayocp.2015.10.027_bib5","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/j.1464-410X.2011.10131.x","article-title":"Anabolic steroids and male infertility: a comprehensive review","volume":"108","author":"de Souza","year":"2011","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.mayocp.2015.10.027_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biopsych.2011.06.024","article-title":"Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study","volume":"71","author":"Pope","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mayocp.2015.10.027_bib7","first-page":"15","article-title":"About anabolic steroid abuse","volume":"15","author":"National Institute on Drug Abuse","year":"2000","journal-title":"NIDA Notes"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.027_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1472-8206.2004.00298.x","article-title":"Pharmacoepidemiology of anabolic androgenic steroids: a review","volume":"19","author":"Thiblin","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.10.027_bib9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1249\/01.mss.0000210194.56834.5d","article-title":"Anabolic androgenic steroids: a survey of 500 users","volume":"38","author":"Parkinson","year":"2006","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"10.1016\/j.mayocp.2015.10.027_bib10","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1360-0443.2004.00781.x","article-title":"Anabolic steroid users' attitudes towards physicians","volume":"99","author":"Pope","year":"2004","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.mayocp.2015.10.027_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement","volume":"35","author":"Pope","year":"2014","journal-title":"Endocr Rev"},{"issue":"8","key":"10.1016\/j.mayocp.2015.10.027_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.eurpsy.2005.09.001","article-title":"Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse","volume":"21","author":"Pagonis","year":"2006","journal-title":"Eur Psychiatry"},{"issue":"11","key":"10.1016\/j.mayocp.2015.10.027_bib13","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1360-0443.2006.01568.x","article-title":"Doping in fitness sports: estimated number of unreported cases and individual probability of doping","volume":"101","author":"Simon","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.mayocp.2015.10.027_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1550-2783-4-12","article-title":"A\u00a0league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States","volume":"4","author":"Cohen","year":"2007","journal-title":"J\u00a0Int Soc Sports Nutr"},{"issue":"8","key":"10.1016\/j.mayocp.2015.10.027_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1592\/phco.31.8.757","article-title":"The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training","volume":"31","author":"Ip","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.mayocp.2015.10.027_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1521-0391.2013.12118.x","article-title":"The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates","volume":"23","author":"Pope","year":"2014","journal-title":"Am J Addict"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.027_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(03)00069-3","article-title":"Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study","volume":"71","author":"Kanayama","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.mayocp.2015.10.027_bib18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/j.1875-9114.2012.01123","article-title":"Psychological and physical impact of anabolic-androgenic steroid dependence","volume":"32","author":"Ip","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.mayocp.2015.10.027_bib19","series-title":"Historical Marriage Trends From 1890\u20132010: A Focus on Race Differences. SEHSD Working Paper 2012-12","author":"Elliott","year":"2012"},{"issue":"9","key":"10.1016\/j.mayocp.2015.10.027_bib20","first-page":"17","article-title":"Self-employment in the United States","volume":"133","author":"Hipple","year":"2010","journal-title":"Monthly Labor Rev"},{"key":"10.1016\/j.mayocp.2015.10.027_bib21","series-title":"Income and Poverty in the United States: 2014","first-page":"60","author":"DeNavas-Walt","year":"2015"},{"issue":"6","key":"10.1016\/j.mayocp.2015.10.027_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1360-0443.1991.tb03101.x","article-title":"Symptoms and correlates of anabolic-androgenic steroid dependence","volume":"86","author":"Brower","year":"1991","journal-title":"Br J Addict"},{"issue":"20","key":"10.1016\/j.mayocp.2015.10.027_bib23","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM200005183422018","article-title":"Anabolic-androgenic steroids as a gateway to opioid dependence","volume":"342","author":"Arvary","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mayocp.2015.10.027_bib24","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1360-0443.2009.02734.x","article-title":"Anabolic-androgenic steroid dependence: an emerging disorder","volume":"104","author":"Kanayama","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.mayocp.2015.10.027_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugalcdep.2015.04.013","article-title":"Anabolic steroids and cardiovascular risk: a national population-based cohort study","volume":"152","author":"Thiblin","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.027_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yhbeh.2009.09.006","article-title":"Illicit anabolic-androgenic steroid use","volume":"58","author":"Kanayama","year":"2010","journal-title":"Horm Behav"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.027_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0376-8716(00)80011-3","article-title":"Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users","volume":"60","author":"Copeland","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"2-3","key":"10.1016\/j.mayocp.2015.10.027_bib28","first-page":"100","article-title":"The use of anabolic androgenic steroids and polypharmacy: a review of the literature","volume":"114","author":"Dodge","year":"2011","journal-title":"Drug Alcohol Depend"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615008903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615008903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T10:53:02Z","timestamp":1537095182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619615008903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0025619615008903"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.10.027","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heavy Testosterone Use Among Bodybuilders","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}